Total Return Level Chart

Historical Total Return Level Data

View and export this data back to 1990. Start Trial.
Date Value
October 22, 2026 455.32
October 21, 2026 463.49
October 20, 2026 458.60
October 19, 2026 444.16
October 16, 2026 451.34
October 15, 2026 448.99
October 14, 2026 455.73
October 13, 2026 439.06
October 12, 2026 449.79
October 09, 2026 450.25
October 08, 2026 440.30
October 07, 2026 441.56
October 06, 2026 438.94
October 05, 2026 431.51
October 02, 2026 446.23
October 01, 2026 444.72
September 30, 2026 449.36
September 29, 2026 461.63
September 28, 2026 459.81
September 25, 2026 460.09
September 24, 2026 457.61
September 23, 2026 457.92
September 22, 2026 466.67
September 21, 2026 462.31
September 18, 2026 454.18
Date Value
September 17, 2026 455.05
September 16, 2026 448.12
September 15, 2026 444.66
September 14, 2026 445.30
September 11, 2026 442.47
September 10, 2026 444.87
September 09, 2026 453.54
September 08, 2026 456.40
September 04, 2026 462.15
September 03, 2026 468.33
September 02, 2026 466.18
September 01, 2026 460.70
August 31, 2026 454.25
August 28, 2026 456.06
August 27, 2026 459.72
August 26, 2026 470.66
August 25, 2026 480.96
August 24, 2026 463.16
August 21, 2026 468.97
August 20, 2026 458.03
August 19, 2026 467.90
August 18, 2026 415.54
August 17, 2026 418.00
August 14, 2026 417.60
August 13, 2026 416.71

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
Johnson & Johnson 638.57
Eli Lilly & Co. 3452.55
Pfizer Inc. 101.75
Bristol Myers Squibb Co. 240.81
Viatris, Inc. 23.13